Indefinite Delivery Contract SPE2D021DA002

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $30.9 million contract has a period of performance through March 2031 and supports the routine pharmaceutical and medical supply needs of military treatment facilities worldwide. DMS Pharmaceutical Group holds multiple DLA contracts and delivery orders to provide a wide range of products, including epinephrine injections, naloxone, insulin, antibiotics, and vaccines. The original pre-solicitation for this IDC sought vendors to participate in DLA's Vendor Managed Inventory program, which aims to ensure industrial base preparedness and provide the government with improved commercial asset visibility data. Awards were made to offerors with technically acceptable proposals offering the most advantageous business terms. The IDC utilizes firm-fixed-price delivery orders issued against established pricing agreements such as Federal Supply Schedules.

DLA Troop Support Medical has issued numerous delivery orders under this IDC to DMS Pharmaceutical Group for the supply of essential pharmaceutical items and medical products. These firm-fixed-price orders, valued up to several million dollars each, procure items like epinephrine autoinjectors, diazepam injection, naloxone, and various antibiotics and vaccines with completion dates through 2024. The IDC and associated delivery orders support the routine medical needs of military treatment facilities operated by the Department of Defense, ensuring the availability and timely delivery of critical pharmaceutical supplies.